A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Ocular Hypertension
Related studies linked through entity extraction aliases.
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan
- Status
- COMPLETED
- Phase
- NA
Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
- Status
- COMPLETED
- Phase
- PHASE3
A Long-term Safety Study of Once-daily Travatan
- Status
- COMPLETED
- Phase
- PHASE3
A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)
- Status
- COMPLETED
- Phase
- PHASE3
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
- Status
- COMPLETED
- Phase
- PHASE3
Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32
- Status
- TERMINATED
- Phase
- PHASE4
Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98
- Status
- COMPLETED
- Phase
- PHASE3
Study of TRAVATAN in Subjects With Iris Pigmentation Changes
- Status
- TERMINATED
- Phase
- N/A
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70
- Status
- COMPLETED
- Phase
- PHASE3
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41
- Status
- COMPLETED
- Phase
- PHASE3
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69
- Status
- COMPLETED
- Phase
- PHASE3